Phibro Animal Health Corp. announced Jan. 9 that its V-Max (virginiamycin) medicated feed additive has received regulatory approval in Canada by the Veterinary Drugs Directorate (VDD) within Health Canada for use in beef cattle.
According to Phibro, V-Max is approved for the reduction of incidence of liver abscesses in cattle fed in confinement, which is a condition that affects the well-being of an estimated one in five feedlot cattle in Canada.
Liver abscesses negatively affect cattle health and well-being, causing significant losses to cattle producers. When the product was included in feed, cattle showed significant reductions in liver abscesses in recent commercial feedlot trials in Canada, the company said.
Phibro has a similar approval for its V-Max product in the U.S.
Phibro is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources.